Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.
Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.
复制标题
DOI:
10.1016/j.anaerobe.2021.102387
复制
发表时间:
2021-08
期刊:
影响因子:
2.3
通讯作者:
Garey KW
中科院分区:
文献类型:
--
作者:
Gonzales-Luna AJ;Spinler JK;Oezguen N;Khan MAW;Danhof HA;Endres BT;Alam MJ;Begum K;Lancaster C;Costa GP;Savidge TC;Hurdle JG;Britton R;Garey KW
Fecal microbiota transplantation (FMT) aims to cure Clostridioides difficile infection (CDI) through reestablishing a healthy microbiome and restoring colonization resistance. Although often effective after one infusion, patients with continued microbiome disruptions may require multiple FMTs. In this N-of-1 study, we use a systems biology approach to evaluate CDI in a patient receiving chronic suppressive antibiotics with four failed FMTs over two years. Seven stool samples were obtained between 2016-18 while the patient underwent five FMTs. Stool samples were cultured for C. difficile and underwent microbial characterization and functional gene analysis using shotgun metagenomics. C. difficile isolates were characterized through ribotyping, whole genome sequencing, metabolic pathway analysis, and minimum inhibitory concentration (MIC) determinations. Growing ten strains from each sample, the index and first four recurrent cultures were single strain ribotype F078-126, the fifth was a mixed culture of ribotypes F002 and F054, and the final culture was ribotype F002. One single nucleotide polymorphism (SNP) variant was identified in the RNA polymerase (RNAP) β-subunit RpoB in the final isolated F078-126 strain when compared to previous F078-126 isolates. This SNV was associated with metabolic shifts but phenotypic differences in fidaxomicin MIC were not observed. Microbiome differences were observed over time during vancomycin therapy and after failed FMTs. This study highlights the importance of antimicrobial stewardship in patients receiving FMT. Continued antibiotics play a destructive role on a transplanted microbiome and applies selection pressure for resistance to the few antibiotics available to treat CDI.
登录
查看更多内容
DOI:
10.1056/nejmoa1910215
发表时间:
2020-04-02
期刊:
The New England journal of medicine
影响因子:
--
作者:
Guh AY;Mu Y;Winston LG;Johnston H;Olson D;Farley MM;Wilson LE;Holzbauer SM;Phipps EC;Dumyati GK;Beldavs ZG;Kainer MA;Karlsson M;Gerding DN;McDonald LC;Emerging Infections Program Clostridioides difficile Infection Working Group
通讯作者:
Emerging Infections Program Clostridioides difficile Infection Working Group
DOI:
10.1093/jac/dkv498
发表时间:
2016-05
期刊:
The Journal of antimicrobial chemotherapy
影响因子:
--
作者:
Bassères E;Endres BT;Khaleduzzaman M;Miraftabi F;Alam MJ;Vickers RJ;Garey KW
通讯作者:
Garey KW
影响因子:
15.5
作者:
Fadrosh DW;Ma B;Gajer P;Sengamalay N;Ott S;Brotman RM;Ravel J
通讯作者:
Ravel J
DOI:
10.1093/cid/cis499
发表时间:
2012-08
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Crook DW;Walker AS;Kean Y;Weiss K;Cornely OA;Miller MA;Esposito R;Louie TJ;Stoesser NE;Young BC;Angus BJ;Gorbach SL;Peto TE;Study 003/004 Teams
通讯作者:
Study 003/004 Teams
影响因子:
11.8
作者:
Beyda, Nicholas D.;John, Julie;Garey, Kevin W.
通讯作者:
Garey, Kevin W.